Remove CMS Remove Diabetes Remove Medicaid
article thumbnail

Weight Loss Drugs Land Medicare Coverage for Cardiovascular Events

CardiacWire

Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.

article thumbnail

Abstract 280: Risk Factors in 90day Ischemic Stroke Readmissions

Stroke: Vascular and Interventional Neurology

Factors considered in analysis include patient age, sex, geographic region, Medicaid dual eligibility, disability status prior to age 65, comorbidities, admission length of stay, discharge disposition, and hospital characteristics. 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient